Edwards highlights commitments to JenaValve integration at US trial with FTC
Edwards Lifesciences' plans with JenaValve and its outlook on future market participants were highlighted by both sides during the companies’ US trial today with the Federal Trade Commission. In the face...To view the full article, register now.
Already a subscriber? Click here to view full article